Zhongqi Capital
Overview
Zhongqi Capital is a private equity investment firm established in 2018, focusing on materials science, life sciences, and advanced manufacturing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanjing Delova Biotech Co., Ltd. | Apr 2024 | Series B Extension | Co-investor |
| Shanghai Langxi Technology Co., Ltd. | Sep 2026 | Private Equity | Co-investor |
| LaSense Technology Limited | Jul 2022 | Early Funding | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zhongqi Capital based?
Zhongqi Capital is headquartered in Beijing, China.
When was Zhongqi Capital founded?
Zhongqi Capital was founded in 2018.
How many portfolio companies does Zhongqi Capital have?
Zhongqi Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Zhongqi Capital's portfolio?
Portfolio companies visible on Caplight include Nanjing Delova Biotech Co., Ltd., Shanghai Langxi Technology Co., Ltd., LaSense Technology Limited.
What was Zhongqi Capital's most recent investment shown here?
Zhongqi Capital's most recent investment in this portfolio sample was in Shanghai Langxi Technology Co., Ltd. in 2026.
What sectors does Zhongqi Capital focus on?
Zhongqi Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does Zhongqi Capital focus on?
Stage focus information for Zhongqi Capital is not publicly available.
What is Zhongqi Capital's AUM?
Zhongqi Capital's assets under management are estimated between $551.7M and $689.7M.